LGMN and neoplasm: To confirm these findings in vivo, we treated the mice bearing CT2A tumors, where LGMN is highly expressed in TAMs (37), with WP1066 and AR-1014418, and analyzed the change of macrophages in tumor tissues using flow cytometry and IF.